FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5509511000001103: Co-careldopa 25mg/250mg tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22932501000001112 Co-careldopa 25mg/250mg tablets 50 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22932601000001111 Co-careldopa 25mg/250mg tablets 50 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 25mg/250mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has VMP Co-careldopa 25mg/250mg tablets true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has VMP Co-careldopa 25mg/250mg tablets false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Is pack of Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has VMP Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets 50 tablet Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-careldopa 25mg/250mg tablets (PI) (Dowelhurst Ltd) 50 tablet 5 x 10 tablets Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Sinemet 275 tablets (PI) (Dowelhurst Ltd) 50 tablet 5 x 10 tablets Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Sinemet 275 tablets (Doncaster Pharmaceuticals Ltd) 50 tablet Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Sinemet 275 tablets (Sigma Pharmaceuticals Plc) 50 tablet Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Stephar (U.K.) Ltd) 50 tablet Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) 50 tablet Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Bristol Laboratories Ltd) 50 tablet 5 x 10 tablets Is a True Co-careldopa 25mg/250mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start